CSMYF (COSMOS Pharmaceutical) Cyclically Adjusted PB Ratio: (As of Jul. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSMYF COSMOS Pharmaceutical Corp CSMYF
93 GF Score
Price $37.06
GF Value $50.48
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is COSMOS Pharmaceutical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


COSMOS Pharmaceutical  (OTCPK:CSMYF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


COSMOS Pharmaceutical Cyclically Adjusted PB Ratio Related Terms


COSMOS Pharmaceutical Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for COSMOS Pharmaceutical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical Cyclically Adjusted PB Ratio Chart

COSMOS Pharmaceutical Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.64 4.26 3.50 4.20 0.00

COSMOS Pharmaceutical Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.20 4.10 3.32 0.00 0.00

COSMOS Pharmaceutical Cyclically Adjusted PB Ratio Competitor Comparison

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


COSMOS Pharmaceutical Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's Cyclically Adjusted PB Ratio falls into.


CSMYF
93GF Score
COSMOS Pharmaceutical Corp CSMYF
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

COSMOS Pharmaceutical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

COSMOS Pharmaceutical's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2026 is calculated as:

For example, COSMOS Pharmaceutical's adjusted Book Value per Share data for the three months ended in Feb. 2026 was:

Adj_Book=Book Value per Share/CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=22.31/112.2000*112.2000
=22.310

Current CPI (Feb. 2026) = 112.2000.

COSMOS Pharmaceutical Quarterly Data

Book Value per Share CPI Adj_Book
201605 8.837 98.200 10.097
201608 9.993 97.900 11.453
201611 9.806 98.600 11.159
201702 9.779 98.100 11.185
201705 10.468 98.600 11.912
201708 11.129 98.500 12.677
201711 11.187 99.100 12.666
201802 12.064 99.500 13.604
201805 12.534 99.300 14.162
201808 12.842 99.800 14.438
201811 13.036 100.000 14.626
201902 13.757 99.700 15.482
201905 14.500 100.000 16.269
201908 15.488 100.000 17.378
201911 15.541 100.500 17.350
202002 15.890 100.300 17.775
202005 17.158 100.100 19.232
202008 18.102 100.100 20.290
202011 19.056 99.500 21.488
202102 19.770 99.800 22.226
202105 19.740 99.400 22.282
202108 20.131 99.700 22.655
202111 19.959 100.100 22.372
202202 20.129 100.700 22.428
202205 18.669 101.800 20.576
202208 18.238 102.700 19.925
202211 17.748 103.900 19.166
202302 19.316 104.000 20.839
202305 19.446 105.100 20.760
202308 18.777 105.900 19.894
202311 18.620 106.900 19.543
202402 18.914 106.900 19.852
202405 18.734 108.100 19.445
202408 20.462 109.100 21.043
202411 19.986 110.000 20.386
202502 20.712 110.800 20.974
202505 22.422 111.800 22.502
202508 22.471 112.100 22.491
202511 21.888 113.200 21.695
202602 22.310 112.200 22.310

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?

Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued. The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48. GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.

Key valuation signals for CSMYF:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


COSMOS Pharmaceutical Business Description

Other Exchanges 3349:Japan
Address 10-1 Hakataeki Higashi 2-chome, 4th floor, JR Hakata Station East NS Building S, Hakata-ku, Fukuoka Prefecture, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score

Get the complete analysis for CSMYF

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.06
Price
$50.48
GF Value